ANGUS Chemical Company has been divested by The Dow Chemical Company through an investment by private equity firm Golden Gate Capital. ANGUS is dedicated to the manufacture and distribution of nitroalkanes and their derivatives.
ANGUS will continue to be led by its current senior management team, including president and CEO Mark A. Henning. Additionally, ANGUS will continue to honor all customer, licensing and supplier contracts and related agreements.
As previously announced, the $1.215 billion transaction includes the ANGUS business headquarters and R&D facility in Buffalo Grove, IL, USA; manufacturing facilities located in Sterlington, LA, USA and Ibbenbueren, Germany; a life-science additive facility in Niagara Falls, NY, USA; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.
Golden Gate Capital is looking to invest in ANGUS's targeted growth areas, including paints and coatings, metalworking fluids and personal care.